文献
J-GLOBAL ID:201802268087613208
整理番号:18A0329566
細胞毒性薬,EGFRおよびerbB2受容体阻害剤としての置換ベンゾイミダゾール結合したオキサジアゾールの設計,合成,ドッキングおよびQSAR研究【Powered by NICT】
Design, synthesis, docking and QSAR study of substituted benzimidazole linked oxadiazole as cytotoxic agents, EGFR and erbB2 receptor inhibitors
著者 (7件):
Akhtar Md Jawaid
(Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hamdard University, Hamdard Nagar, New Delhi-110062, India)
,
Siddiqui Anees Ahmad
(Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hamdard University, Hamdard Nagar, New Delhi-110062, India)
,
Khan Ahsan Ahmed
(Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hamdard University, Hamdard Nagar, New Delhi-110062, India)
,
Ali Zulphikar
(Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hamdard University, Hamdard Nagar, New Delhi-110062, India)
,
Dewangan Rikeshwer Prasad
(Lab No 405, Institute of Genomics and Integrative Biology, New Delhi, India)
,
Pasha Santosh
(Lab No 405, Institute of Genomics and Integrative Biology, New Delhi, India)
,
Yar M. Shahar
(Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hamdard University, Hamdard Nagar, New Delhi-110062, India)
資料名:
European Journal of Medicinal Chemistry
(European Journal of Medicinal Chemistry)
巻:
126
ページ:
853-869
発行年:
2017年
JST資料番号:
E0845A
ISSN:
0223-5234
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)